Health Condition 1: D509- Iron deficiency anemia, unspecified
Conditions
Interventions
Intervention1: HAEMO-BITE PRO: Participants will receive a chewable nutritional supplement containing iron folic acid vitamin C and probiotic Lactobacillus rhamnosus GG for two months. The supplement
Sponsors
Srinivasan S
Eligibility
Inclusion criteria
Inclusion criteria: Female participants aged 18 45 years with mild anaemia, defined as hemoglobin levels between 10.0 and 11.9 g/dL, who are willing to provide written informed consent will be included in the study. Participants must be residents of the study area and available for the entire study duration, including scheduled follow-up visits.
Exclusion criteria
Exclusion criteria: Participants will be excluded if they are male individuals outside the age range of 18 45 years, have moderate or severe anaemia hemoglobin less than 10 g/dL, are pregnant or lactating, have known hemoglobinopathies or any chronic medical illness, are currently receiving iron therapy or probiotic supplementation, or have a history of hypersensitivity or allergy to any of the study ingredients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study is the change in hemoglobin concentration g/dL from baseline to the end of the intervention period at 2 months 8 weeks. Hemoglobin levels will be assessed at baseline Day 0 and at the completion of 2 months.Timepoint: Outcome will be estimated at baseline, 4 weeks and 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes include gastrointestinal tolerability assessed by the occurrence of symptoms such as nausea, constipation, abdominal discomfort, or diarrhea, participant compliance assessed by tablet count & self report, & the incidence of adverse events recorded during the 2 month intervention periodTimepoint: Outcome will be estimated at baseline, 4 weeks & 8 weeks | — |
Countries
India
Contacts
Public ContactSrinivasan S
SAVEETHA MEDICAL COLLEGE AND HOSPITAL
Outcome results
None listed